ArticleJournal of thrombosis and thrombolysis2022

Incidence of thrombotic complications related to weight-based dosing of activated prothrombin complex concentrate (aPCC) for reversal of apixaban and rivaroxaban in obese patients.

Caitlyn Whitaker et al.PubMed ↗Publisher ↗

No numbers read from the abstract.